Valuation: genOway

Market Cap 23.05M 26.27M 21.46M 19.74M 37.01M 2.51B 37.64M 255M 99.67M 1.24B 98.61M 96.48M 4.3B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.77M 33.92M 27.72M 25.5M 47.8M 3.24B 48.61M 329M 129M 1.61B 127M 125M 5.55B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-1.60%
1 week-1.60%
Current month+3.80%
1 month+4.24%
6 months-3.53%
Current year-9.23%
1 week 2.46
Extreme 2.46
2.51
1 month 2.21
Extreme 2.21
2.63
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Director/Board Member - -
Director/Board Member 74 -
Date Insider Type Main position Quantity % Market Cap.
1/20/22 Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-1.60%-1.60%-18.27%-35.60% 26.22M
+0.14%-0.67%-0.88%+11.02% 47.74B
-2.92%-0.72%+388.38%+607.78% 39.98B
+0.30%+2.66%+11.09%+45.32% 36.23B
+13.13%+19.54%+21.87%+6.57% 35.59B
-0.73%+2.78%+4.65%+41.16% 27.91B
-2.21%-2.90% - - 16.71B
-0.48%+9.88%+28.95%+129.27% 16.45B
+2.39%-1.64%+4.74%+9.95% 13.21B
+7.67%+8.46%-4.71%-28.33% 12.93B
Average +1.59%+2.58%+48.42%+87.46% 24.68B
Weighted average by Cap. +1.82%+2.95%+75.08%+129.27%

Financials

2024 2025
Net sales 27.53M 31.37M 25.64M 23.58M 44.2M 3B 44.96M 304M 119M 1.49B 118M 115M 5.14B 28.6M 32.59M 26.63M 24.5M 45.92M 3.11B 46.71M 316M 124M 1.54B 122M 120M 5.33B
Net income 1.83M 2.09M 1.7M 1.57M 2.94M 199M 2.99M 20.23M 7.92M 98.84M 7.83M 7.66M 341M 928K 1.06M 864K 795K 1.49M 101M 1.52M 10.25M 4.01M 50.09M 3.97M 3.88M 173M
Net Debt 623K 710K 580K 534K 1M 67.82M 1.02M 6.88M 2.69M 33.63M 2.66M 2.61M 116M 6.72M 7.66M 6.26M 5.75M 10.79M 731M 10.97M 74.22M 29.05M 363M 28.74M 28.12M 1.25B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-07-28 2.460 -1.60% 736
26-07-27 €2.500 +0.81% 3,349
26-07-24 €2.480 +0.40% 13,571
26-07-23 €2.470 -1.20% 17,468
26-07-22 €2.500 0.00% 1,510
  1. Stock Market
  2. Stocks
  3. ALGEN Stock